National Health Act 1953 Declaration under subsection 85(2AA) (No. PB 3 of 1992) (Cth)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85 (2AA)

No. PB 3 of 1992

I, ALAN WILLIAM STEVENS, Acting Principal Advisor, Health Care Access Division, Department of Health, Housing and Community Services and Delegate of the Minister of State for Health, Housing and Community Services, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:

1. This Declaration shall come into operation on 1 April 1992.

2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Aluminium Hydroxide and Magnesium Carbonate Co-dried Gel

Chloramphenicol Palmitate

Lypressin

Methyltestosterone

Quinidine Sulphate

Semisodium Valproate

Thiethylperazine Maleate

Tolazamide

Coal Tar, Prepared B.P. 1973

Raspberry Syrup B.P.

Sulphurated Potash B.P.C. 1973

Dated this twelfth day of March 1992.

A. STEVENS

Acting Principal Advisor

Health Care Access Division

Department of Health, Housing and Community Services

Delegate of the Minister of State for Health, Housing and Community Services